HOME >> BIOLOGY >> NEWS
GenRISK Genetic Testing Program At Cedars-Sinai Medical Center Offers Patients New Hope In Confronting Disease

LOS ANGELES (March 8, 1999) -- When Marcia Litt was diagnosed with breast cancer at age 48, she was worried about more than her medical outcome. Her fears also focused on the possibility that her children -- and other family members -- could develop the same disease. Marcia had already seen two of her aunts succumb to breast cancer, and began to wonder if there might be a genetic susceptibility to the disease within her family.

"I gradually became proactive about educating myself about cancer," said Marcia, who underwent a lumpectomy, lymph node surgery, radiation and chemotherapy in 1997. Initially she was afraid to explore the subject for fear of learning more than she could emotionally handle. But with time that hesitation turned to action, as she began to seek information about the disease and, ultimately, decide to pursue genetic counseling and testing. She credits that decision with saving her life . . . and possibly the lives of those she loves.

Last year, Marcia was one of more than 130 people evaluated by the GenRISK program at Cedars-Sinai Medical Center. Program director Maren Scheuner, M.D., M.P.H., hopes that number will grow as more people become aware of both GenRISK and the benefits it can provide in recognizing and reducing the risks of potentially life-threatening diseases.

Utilizing state-of-the-art genetic consultative services, GenRISK provides genetic risk assessment, diagnosis, testing and counseling for such common, chronic conditions as cancer (including breast, colon, endometrial, kidney, ovarian, prostate, skin and thyroid), diabetes, heart disease, hemochromatosis and stroke. The program is designed for individuals who may have a genetic susceptibility to certain conditions.

David L. Rimoin, M.D., Ph.D., Steven Spielberg Chairman of Pediatrics, Director of the Ahmanson Pediatric Center and Director of the Medical Genetics-Birth Defects Center at Cedars-Sinai, calls this ?customized environmental engineering.? ?Why give
'"/>

Contact: Sandra Van
Sandy@VanCommunications.com
1-800-396-1002
Cedars-Sinai Medical Center
8-Mar-1999


Page: 1 2 3 4 5

Related biology news :

1. Genetic mutations linked to the practice of burning coal in homes in China
2. Genetic differences might help distinguish thyroid cancers
3. Genetic modification of linseed produces healthier omega 3 and 6 fatty acids
4. Wiley publishes Welcome to the Genome: A Users Guide to the Genetic Past, Present, and Future
5. Genetically modified bacterium as remedy for intestinal diseases
6. Genetic analysis rewrites salamanders evolutionary history
7. Genetic map of important tree genes outlined
8. Genetically-engineered marathon mouse keeps on running
9. Genetic clues found for common congenital brain disorder
10. Genetic mutation linked to more aggressive breast cancer found more often in African-Americans
11. Genetic discovery could dramatically reduce need for liver transplants in children

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/2/2020)... ... July 01, 2020 , ... AltruBio Inc. ... of Neihulizumab, a biologic for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD), ... Dr. Paul J Martin of the Fred Hutchinson Cancer Research Center, this single-arm, ...
(Date:6/28/2020)... , ... June 25, 2020 ... ... enterprise software solutions for biopharmaceutical R&D, today announced that it has entered ... innovative, full-length multispecific antibodies (Multiclonics®), to support their translational and clinical research ...
(Date:6/23/2020)... MILTON KEYNES, England (PRWEB) , ... June 23, ... ... operations in Africa supporting sustainable healthcare, and Renovagen Ltd, a UK supplier and ... rapid response project to support testing operations in the fight against the COVID-19 ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... ... 2020 , ... R3 Stem Cell International is now offering patients the opportunity ... cells total, patients may choose which extremities they would like treated. , Several studies ... Disord. 2016). At R3 International, umbilical cord tissue is obtained from a lab with ...
(Date:7/31/2020)... ... July 29, 2020 , ... Editas Medicine, ... provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell ... into a strategic partnership whereby Catalent will provide support for the development, manufacturing, ...
(Date:7/22/2020)... ... July 22, 2020 , ... Join experts from ... Sr. Manager Regulatory Solutions, in a one hour live webinar on Thursday, ... body in China for drugs and medical devices. Specifically, for medical devices, the NMPA ...
(Date:7/18/2020)... ... July 17, 2020 , ... dicentra , a leading ... food industries, is pleased to announce that Charles Galea has joined its clinical ... Charles is an accomplished and results-driven sales executive with over 10 years of ...
Breaking Biology Technology:
Cached News: